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BACKGROUND: Osteoporosis screening rates are low,
and it is unclear which patient factors are associated
with screening and physician recommendations for
screening.
OBJECTIVE: To identify patient characteristics associ-
ated with osteoporosis screening recommendations and
receipt of screening in older adults.
DESIGN: Cross-sectional mailed survey.
PARTICIPANTS: Women and men ≥60 years old living
in or near western Pennsylvania.
MEASUREMENTS: Sociodemographic characteristics
and osteoporosis-related data, including risk factors,
physician recommendations for screening, and receipt
of screening. Multivariable logistic regression analyses
were performed to determine odds ratios for receipt of
screening and screening recommendations for indivi-
duals with particular osteoporosis risk factors, adjust-
ing for sociodemographic and other risk factors.
RESULTS: Surveys were completed by 1,268 of the
1,830 adults to whom surveys were mailed (69.3%).
Most respondents were white (92.9%), female (58.7%),
and believed they were in good to excellent health
(88.2%). Only 47.6% said their physician recommended
osteoporosis screening, and 62.6% of all respondents
reported being screened. Screening recommendations
were less likely for older respondents than younger ones
(OR, 0.87 per 5-year increase in age; 95% CI, 0.77–
0.97). Individuals with osteoporosis risk factors of a
history of oral steroid use for >1 month, height loss
>2.54 cm, or history of low-trauma fracture were no
more likely to report screening recommendations than
individuals without these characteristics. Receipt of
screening was no more likely for more elderly respon-
dents or respondents with a history of oral steroid use
for >1 month than for respondents without these
characteristics.
CONCLUSIONS: Individuals with several known osteo-
porosis risk factors are not being sufficiently targeted
for screening.
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INTRODUCTION
Osteoporosis is common and costly, affecting 10 million
women and men in the United States, with direct costs of
$17 billion in 2005.
1–3 Studies suggest that approximately
one-half of all postmenopausal women and one-quarter of
white men over 60 years of age will sustain an osteoporotic
fracture in their lifetime.
4,5 Consequences of osteoporosis can
be severe, including chronic pain, loss of ability to ambulate,
nursing home placement, and mortality.
6–9
There are many risk factors for osteoporosis in older adults.
The Study of Osteoporotic Fractures, a large, prospective US
study of close to 10,000 women aged 65 and older, identified
14 clinical risk factors for osteoporotic hip fracture in multi-
variable models: age, maternal hip fracture, personal history of
any fracture since age 50, height, poor self-rated health, no
weight gain, hyperthyroidism, not walking for exercise, lack of
ambulation, inability to rise from a chair, poor vision, high
resting pulse, and current use of benzodiazepines, antic-
onvulsants, or caffeine.
10 The World Health Organization
recently released a fracture risk assessment tool (FRAX) that
incorporates clinical risk factors identified from population-
based cohorts to predict individuals’ 10-year probability of
osteoporotic fracture.
11 Clinical risk factors assessed by the
FRAX tool are age, sex, history of prior spontaneous or low-
trauma fracture, weight, height, parental history of hip
fracture, current smoking, alcohol intake 3 or more units per
day, presence of a medical condition associated with secondary
osteoporosis (e.g., hypogonadism), oral glucocorticoid use for 3
or more months (ever), and rheumatoid arthritis.
11
Several organizations, including the US Preventive Ser-
vices Task Force (USPSTF), the American College of Physi-
cians (ACP), and the National Osteoporosis Foundation
(NOF), recommend that clinicians screen older adults for
osteoporosis.
12–14 The USPSTF recommends that all women
aged 65 and older should be screened for osteoporosis.
12 The
2008 NOF guidelines suggest that all women aged 65 and
older and men aged 70 and older be screened.
13 The ACP
recommends that clinicians periodically assess men aged 70
and older for osteoporosis risk factors and perform dual-
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585energy X-ray absorptiometry in those who are at increased
risk and are candidates for medical therapy.
14 These organi-
zations also recommend that younger individuals with
additional osteoporosis risk factors be screened.
12–14 Despite
these guidelines, studies indicate that most individuals with
osteoporosis remain undiagnosed and untreated.
15–17
The objective of our study was to identify patient character-
istics associated with physician recommendations for osteopo-
rosis screening and receipt of screening in older adults. We
hypothesized that individuals with known osteoporosis risk
factors of older age, female sex, white race, family history of
osteoporosis, low body weight, current smoking, heavy alcohol
use, history of oral steroid use, height loss over the lifetime, and
history of a low-trauma fracture would be more likely to receive
a screening recommendation or report screening. We also
hypothesized that individuals with higher self-rated health
status, higher educational attainment, use of arms to get up
from a chair most of the time, or history of a recent fall would be
more likely to receive screening or a screening recommendation.
METHODS
Study Participants and Procedures
We performed a cross-sectional survey of 1,830 women and
men who were 60 years of age or older, were living in or near
western Pennsylvania, and were enrolled in the university’s
Claude D. Pepper Registry for studies on mobility and balance
in older adults. The National Institutes of Health and the
University of Pittsburgh developed the Claude D. Pepper
Center to investigate mobility and balance in old age. To
further their mission, the Claude D. Pepper Center developed
the Pepper Center Research Registry, a list of people who have
consented to be contacted for participation in research studies.
Individuals had been recruited for this registry through
community events, newspaper and TV advertisements, other
clinical studies, targeted mailings to voter registration lists in
low-income neighborhoods or neighborhoods enriched with
minority elderly, and mailings to university alumni, faculty,
and staff. Registry recruitment began in May of 2005. Approx-
imately one-third of participants were recruited from other
clinical studies for which they were ineligible, one-third were
recruited from mailings to University of Pittsburgh alumni,
faculty, or staff, and the remainder were recruited from
community events, advertisements, and mailings.
Individuals who expressed interest in the registry completed a
15–20-min interview in which they provided basic health infor-
mation.Mostinterviewswerecompletedbytelephone;individuals
recruited at community events completed interviews in person.
Eligibility for the registry was simply based on age and residence,
whichwereestablishedinthisinterview.Peopleplanningtomove,
on hospice, in a skilled nursing facility, or unable to do the phone
interviews were excluded. Everyone else was eligible.
Approximately 68% of individuals who expressed interest in
the Pepper Registry and were contacted subsequently enrolled.
The most common reason for lack of enrollment after contact
was disinterest after learning more about the registry. Reten-
tion in the registry has been excellent; only about 10% of the
sample has been lost to follow-up.
In November 2007, we mailed all individuals who were
enrolled in the registry a 44-item survey, information describing
the purpose of our study and assurance that survey responses
would remain anonymous, and a prepaid return envelope. Of
the 1,830 individuals enrolled in the registry at this time, mean
age was 74, 60.3% were female, 89.3% were white, and 76.7%
had completed college. Only one mailing was performed, and no
incentives were used or reminders were sent. We collected
completed surveys over a 6-month period, and two individuals
independently entered all survey responses into a database and
validated the data to ensure integrity.
The survey asked respondents about sociodemographics,
knowledge of osteoporosis, osteoporosis risk factors, mobility,
falls, and health beliefs about osteoporosis. It also asked
whether respondents had a personal history of osteoporosis,
had received a recommendation for osteoporosis screening
from their physician, and had been screened. The Appendix
includes survey questions relevant to this study.
We received approval from the University of Pittsburgh
Institutional Review Board prior to initiation of this study.
Statistical Analysis
We computed descriptive statistics for each survey item. We
also performed logistic regression analyses to determine if
there were associations between each of the two response
variables (receipt of a recommendation for osteoporosis screen-
ing and receipt of screening) and the following potential
explanatory variables: age (coded in 5-year increments), sex,
self-reported race (white vs black), educational level (completed
college vs did not complete college), family history of osteopo-
rosis, self-rated health status (poor/fair vs good/very good/
excellent), weight (coded in increments of 11.4 kg, or 25
pounds), current smoking, alcohol intake (3 or more drinks
in one sitting at least 4 times per week vs less), history of oral
steroid use for >1 month (ever), height loss >2.54 cm (1 inch)
over the lifetime, use of arms to get up from a chair most of the
time, history of a fall within the past 5 years, and history of a
low-trauma fracture (fracture resulting from a fall from
standing height or less).
We included individual explanatory variables that showed a
significant association with each response variable (P≤0.10) as
variable candidates in stepwise, backward selection, multivar-
iable logistic regression models. We checked for evidence of
interactions between variables and multicollinearity. We tested
all possible two-way interaction products between individual
explanatory variables included in the multivariable models. We
considered variables and interaction terms with P values of ≤
0.05 to be significant in the final multivariable models. We
reran all logistic regression analyses for the subset of our
population including only women aged 65 and older and men
aged 70 and older (individuals for whom screening is recom-
mended in many guidelines).
12–14 We used Stata version 10.0
(StataCorp, College Station, TX) to perform all analyses.
RESULTS
Characteristics of Survey Respondents
Of the 1,830 individuals to whom surveys were sent, 1,268
(69.3%) responded (Table 1). Respondents had a mean age of
73.3 years (range, 60–93; SD 7.3) and a mean weight of 76.9 kg
(range, 42.6–147.4; SD 16.9). Most respondents were female
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believed that they were in good to excellent health (88.2%).
Fewer than half (47.6%) said that they had received a
physician recommendation for screening. Of the total group,
62.6% reported being screened, and 22.6% reported being
diagnosed with osteoporosis. Of women aged 65 and older and
men aged 70 and older, 50.2% said they had received a
physician recommendation for screening, and 66.0% of indivi-
duals in this age group reported being screened.
Bivariate Associations
Results of bivariate logistic regression analyses for receipt of a
physician recommendation for osteoporosis screening and
receipt of osteoporosis screening are shown in Table 2. Indi-
vidual factors significantly associated with receipt of a physi-
cian recommendation for osteoporosis screening included age,
female sex, white race, family history of osteoporosis, weight,
heavy alcohol intake, oral steroid use for >1 month, height loss
>2.54 cm, use of arms to get up from a chair, fall within the
past 5 years, and history of a low-trauma fracture. Individual
factors significantly associated with receipt of screening in-
cluded female sex, family history of osteoporosis, weight, heavy
alcohol intake, oral steroid use for >1 month, height loss
>2.54 cm, fall within the past 5 years, and history of a low-
trauma fracture.
Multivariable Models
Receipt of Osteoporosis Screening Recommendation. The
receipt of a physician recommendation for osteoporosis
screening was significantly associated with age, sex, weight,
race, family history of osteoporosis, and use of arms to get up
from a chair (Table 3). Respondents were less likely to report
receiving a recommendation for screening if they were older or
had a higher weight. They were more likely to report receiving a
recommendation for screening if they were female, were white,
had a family history of osteoporosis, or reported using their
arms most of the time to get up from a chair. Because of
multicollinearity, we had to remove two interaction terms from
the model, namely, the interactions between family history and
race, and sex and race. Thus, we could not test all possible
interactions between the variables associated with screening
recommendation. Of the interactions we tested (all remaining
possible interaction products between explanatory variables),
none were statistically significant.
Receipt of a physician recommendation for osteoporosis
screening was not significantly associated with risk factors of
oral steroid use for >1 month, height loss >2.54 cm, history of
low-trauma fracture, heavy alcohol consumption, or smoking.
When we repeated bivariate and multivariable logistic regres-
sion analyses for only women aged 65 and older and men age
70 and older, we found similar results (same variables retained
in the receipt of screening recommendation multivariable
model, with same direction of association and similar strength
of association) with the exception of family history of osteopo-
rosis not being retained in the final multivariable model.
Receipt of Osteoporosis Screening. The receipt of osteoporosis
screening was significantly associated with sex, weight,
family history of osteoporosis, history of low-trauma
fracture, and height loss >2.54 cm (Table 3). Respondents
were more likely to report prior osteoporosis screening if they
were female, had a family history of osteoporosis, or had a
history of low-trauma fracture. Respondents were less likely
to report prior screening if they had a higher weight. There
was a significant positive interaction between loss of height
>2.54 cm and weight (Table 3). When we included this
interaction in the model, loss of height by itself was not a
significant predictor of receipt of screening; that is, loss of
height was only associated with receipt of screening for
individuals of higher weight. There was no evidence of
multicollinearity in this model.
Table 1. Characteristics of the Survey Respondents*†
Characteristics Number (%)
Sociodemographic characteristics
Female sex 664 (58.7)
White race 1,148 (92.9)
Completed college 926 (75.0)
Osteoporosis-related characteristics
Has heard of osteoporosis 1,215 (96.1)
Has received physician recommendation for screening 594 (47.6)
Has been screened or tested for osteoporosis 783 (62.6)
Has been diagnosed with osteoporosis 283 (22.6)
Has had a low-trauma fracture (fracture resulting from a fall from standing height or less) 236 (18.8)
Has a family history of osteoporosis 292 (23.8)
Other health-related characteristics
Has a high self-rated health status (rated as good, very good, or excellent) 1,114 (88.2)
Is a non-smoker 1,248 (98.7)
Has a history of alcohol use ≥4 times per week, ≥3 drinks at a time 32 (2.6)
Has a history of oral steroid use for more than 1 month 103 (8.2)
Has experienced a height loss >2.54 cm (1 inch) over the lifetime 435 (35.3)
Uses arms to get up from a chair most of the time 460 (36.8)
Has fallen within the past 5 years 609 (48.6)
*There were 1,268 survey respondents. However, there were missing data for each of the characteristics listed in this table. The percentages shown here
reflect the percentages of individuals who responded to the question about the characteristic listed. The percentage of missing data for sex was 10.8%, but
percentages of missing data for other characteristics were below 4%. When we compared the gender distribution of survey respondents (58.7% female,
41.3% male) to that of all registry participants (60.3% female, 39.7% male), there was no significant difference (P=0.27)
†Mean age of respondents was 73.3 years (range, 60–93; SD 7.3). Mean weight was 76.9 kg (range, 42.6–147.4; SD 16.9)
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associated with risk factors of increased age, oral steroid use
for >1 month, white race, heavy alcohol consumption, or
smoking. When we repeated bivariate and multivariable
logistic regression analyses for only women aged 65 and older
and men age 70 and older, we found that the same variables
were retained in the final multivariable model for receipt of
osteoporosis screening (sex, weight, family history of osteopo-
rosis, and history of low-trauma fracture), with the same
direction of association and similar strength of association.
DISCUSSION
Our survey of 1,268 women and men aged 60 and older
revealed that individuals with several known osteoporosis risk
factors are not being sufficiently targeted for osteoporosis
screening. Most notably, older respondents were significantly
less likely than younger respondents to report receiving
screening recommendations from their physicians and no
more likely than younger respondents to undergo screening.
This is a notable finding given that age is the strongest
individual risk factor for osteoporosis, with older individuals
being at highest risk. This finding that older individuals are
less likely to be targeted for osteoporosis screening concurs
with the finding of a large-scale study in which researchers
abstracted data from the electronic medical records of patients
seen in ten primary care practices,
18 and highlights an
important area for osteoporosis screening improvement.
In our study, the presence of several other osteoporosis risk
factors—suchasoralsteroiduse >1 month, low-traumafracture,
lossofheight,heavyalcoholconsumption,smoking,orwhiterace
—either did not make physicians more likely to recommend
screening or did not make individuals more likely to undergo
screening, when adjusting for other osteoporosis risk factors.
Several of our results are consistent with results of earlier
Table 2. Bivariate Associations of Patient Characteristics with Osteoporosis Screening Recommendation and Receipt of Screening





OR (95%CI) P value OR (95%CI) P value
Increased age (in 5-year increments) 0.90 (0.84–0.97) 0.01 0.99 (0.91–1.07) 0.75
Female sex 17.10 (12.43–23.52) <0.001 14.09 (10.49–18.94) <0.001
White race 1.91 (1.14–3.23) 0.02 1.29 (0.78–2.14) 0.32
Completed college 0.98 (0.76–1.27) 0.89 0.85 (0.64–1.11) 0.24
Family history of osteoporosis 3.44 (2.59–4.56) <0.001 3.71 (2.68–5.15) <0.001
High self-rated health status 0.75 (0.53–1.07) 0.11 0.98 (0.69–1.41) 0.92
Increased weight (in 11.4 kg increments) 0.54 (0.49–0.60) <0.001 0.57 (0.52–0.62) <0.001
Current smoking 0.85 (0.31–2.30) 0.75 0.52 (0.20–1.36) 0.18
History of alcohol use ≥4 times per week, ≥3 drinks at a time 0.36 (0.16–0.80) 0.01 0.32 (0.15–0.67) 0.002
History of oral steroid use >1 month 2.20 (1.44–3.35) <0.001 1.86 (1.17–2.94) 0.01
Height loss >2.54 cm over the lifetime 1.64 (1.29–2.08) <0.001 2.08 (1.61–2.68) <0.001
Use of arms to get up from a chair most of time 1.24 (0.99–1.57) 0.07 0.93 (0.73–1.19) 0.57
Fall within past 5 years 1.50 (1.20–1.88) <0.001 1.50 (1.19–1.89) 0.001
History of low-trauma fracture (resulting from fall from standing height or less) 2.52 (1.87–3.41) <0.001 3.16 (2.22–4.50) <0.001
Table 3. Multivariable Associations of Patient Characteristics with Osteoporosis Screening Recommendation and Receipt of Screening





OR (95%CI) P value OR (95%CI) P value
Increased age (in 5-year increments) 0.87 (0.77–0.97) 0.01 NR‡–
Female sex 11.71 (8.15–16.82) <0.001 9.18 (6.61–12.74) <0.001
White race 2.95 (1.48–5.88) 0.002 NR‡–
Family history of osteoporosis 2.10 (1.43–3.10) <0.001 2.26 (1.48–3.43) <0.001
Increased weight (in 11.4 kg increments) 0.70 (0.61–0.80) <0.001 0.63 (0.54–0.74) <0.001
Use of arms to get up from a chair most of time 1.56 (1.08–2.25) 0.02 NR‡–
History of low-trauma fracture (resulting from fall from standing height or less) NR‡– 2.05 (1.29–3.23) 0.002
Interaction term: weight × (height loss >2.54 cm over the lifetime) NR‡– 1.35 (1.04–1.75) 0.02
*Hosmer-Lemeshow goodness-of-fit test P value=0.95, indicating adequate fit
†Hosmer-Lemeshow goodness-of-fit test P value=0.73, indicating adequate fit
‡Not retained in final model
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of oral steroid use may not be receiving sufficient osteoporosis
screening concurs with findings from other studies that patients
taking oralsteroids areunderscreened.
19,20Ourobservationthat
osteoporosis screening was more likely in women than men is
also consistent with earlier studies.
18,21 Our finding that osteo-
porosis screening was no more likely in white adults than black
adults, when adjusting for other osteoporosis risk factors, is
different from findings of several previous studies and warrants
further study.
18,22
Our study suggests that physicians need to better assess
older adults’ osteoporosis risk and ensure that high-risk
individuals receive screening. Physicians should in particu-
lar be aware that individuals with advanced age (the most
elderly), height loss, history of low-trauma fracture, and oral
steroid use are at increased risk of osteoporosis. Physicians
should be more vigilant about osteoporosis screening in at-
risk patients in general (e.g., all women over the age of 65),
but pay special attention to individuals with the risk factors
listed above, as our results suggest that these individuals
may be particularly underscreened. Several previous studies
have demonstrated that adults who undergo osteoporosis
testing are more likely to receive treatment;
23–25 thus,
improving screening rates in individuals at greatest risk is
an important step towards improving osteoporosis outcomes.
The best way of improving physician identification of indivi-
duals at increased risk of osteoporosis and referral for
screening is unclear. Several potential strategies to improve
physicians’ osteoporosis screening practices include finan-
cial incentives (e.g., incentive payments for physicians
performing well on Medicare’s Physician Quality Reporting
Initiative (PQRI) osteoporosis screening measures), physician
reminders (e.g., electronic medical record system reminders),
and the use of local opinion leaders. A direct patient
education media campaign may also improve screening
rates–if patients are educated about risk factors, at-risk
individuals may ask their physicians for screening. Further
studies are needed to evaluate the efficacy of various
strategies to improve osteoporosis screening rates; one
recent large randomized controlled trial of physician and/or
patient education to improve osteoporosis testing and treat-
ment rates failed to show any benefit of a brief education
program.
26
To our knowledge, our study is the largest survey of patient
characteristics associated with osteoporosis screening. How-
ever, the study had several limitations. First, because the
survey was based on self-report, there may have been recall
bias concerning the receipt of screening or a screening
recommendation; this is further suggested by our finding that
more people reported prior screening than receiving a screen-
ing recommendation. The wording of our screening recom-
mendation question may also have affected participants’
responses; individuals who had screening recommended by a
non-physician health care provider may have answered “no” to
this question. Moreover, individuals whose physicians’ ordered
an osteoporosis screening test but did not discuss this with the
patient may not have considered this a recommendation.
Another limitation of our study is that the survey population
consisted of individuals who lived in or near western Pennsyl-
vania, volunteered for a research registry, and were dispropor-
tionately white, healthy, and highly educated, which may limit
the generalizability of our results. However, if in this survey
population individuals with several known osteoporosis risk
factors were not more likely to receive a screening recommen-
dation or screening, this may be an even larger problem in the
general population of older adults. Furthermore, our choice of
a 1-month cutoff for oral steroid use associated with increased
risk of osteoporosis is shorter than the 3-month steroid use
duration put forth in several guidelines.
11,13 Although there is
evidence that any oral steroid use increases osteoporosis
risk,
27 our choice of a 1-month cutoff was arbitrary, and we
may have found different results had we chosen a longer
steroid use duration. Finally, our survey did not capture all of
the variables related to physician recommendation of screen-
ing or prior screening; for example, we did not assess body
mass index, whether participants had a regular primary care
physician, had health insurance, were physically active, or had
comorbidities, which are likely related to osteoporosis screen-
ing. Our study also had several notable strengths, including a
large sample size, nearly 70% response rate, inclusion of both
female and male participants, and inclusion of key risk factors
in recently published guidelines for osteoporosis prevention
and treatment.
11,13
In conclusion, we found that individuals with several
osteoporosis risk factors, such as advanced age, oral steroid
use >1 month, loss of height, and history of low-trauma
fracture were either not more likely to receive osteoporosis
screening recommendations or not more likely to undergo
screening, when adjusting for other osteoporosis risk factors.
Our study points to the need for physicians to better assess
older adults’ osteoporosis risk, recommend screening to
individuals at risk, and follow-up with screening for at-risk
individuals. Improving screening rates in individuals at great-
est risk for osteoporosis is an important step towards improv-
ing health outcomes.
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